Results from the company’s Phase I/II trial showed the injectable therapy to have an effective half-life of 91.4 hours.

Lu rhPSMA-10.1 showed high tumor radiation with low healthy tissue exposure in a phase 1/2 trial for metastatic ...

Space is a hostile environment for humans. Even on Mars, settlers might have a hard time coping with potentially lethal ...

Female astronauts drive personalized space medicine, closing knowledge gaps to benefit space travelers and people on Earth.

Anthony Stein, MD, assessed total marrow and lymphoid irradiation with post-transplant cyclophosphamide in patients with ...

Compared with other ablative therapies, stereotactic body radiotherapy might offer a ‘particularly advantageous option’ for ...

TNBC, aggressive and lacking key receptors, complicates treatment, impacting prognosis and requiring specialized approaches.

An eight-day mission has turned into a nine-month space stint for two NASA astronauts who are finally set to come home. But ...

Try light therapy if you're fighting fatigue from the time change or struggling with seasonal depression. Here's how it works ...

Interim results from three trials exploring the use of Alpha DaRT® in treating pancreatic cancer showing high disease control rate, impressive ...

Tubular carcinoma, treatable and slow-growing, has a good prognosis and often needs less aggressive treatment.